Time to Detection of Hepatitis C Virus Infection With the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis

Abstract Background Xpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit diagnosis and treatment. Methods This study evaluated time to HCV RNA detection using the Xpert HCV VL FS assay. Fingerstick whole-blood samples...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 221; no. 12; pp. 2043 - 2049
Main Authors Grebely, Jason, Catlett, Beth, Jayasinghe, Indika, Valerio, Heather, Hajarizadeh, Behzad, Verich, Andrey, Cunningham, Philip, Martinello, Marianne, Tillakeratne, Shane, Silk, David, Dore, Gregory J, Applegate, Tanya L
Format Journal Article
LanguageEnglish
Published US Oxford University Press 11.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Background Xpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit diagnosis and treatment. Methods This study evaluated time to HCV RNA detection using the Xpert HCV VL FS assay. Fingerstick whole-blood samples were collected from participants in an observational cohort in Australia. Results In May 2018–2019, 1468 participants were enrolled, 1426 had Xpert HCV VL FS testing performed, and 1386 had a valid result. HCV RNA was detected in 23% (325/1386). Among people with undetectable HCV RNA (n = 1061), median time to result was 57 minutes. Among people with detectable HCV RNA (n = 325), median time to HCV RNA detection was 32 minutes and 80% (261/325) had a detectable HCV RNA result in ≤40 minutes. Median time to HCV RNA detection was dependent on HCV RNA level. Conclusions A quicker HCV diagnosis could be achieved by monitoring the time when HCV RNA is first detected with the Xpert HCV VL FS test, rather than HCV RNA quantification, although the current platform does not allow for this. These findings could facilitate new strategies to reduce waiting times for an HCV diagnosis and improve linkage to treatment. Among people with detectable HCV RNA, median time to HCV RNA detection was 32 minutes with the Xpert HCV VL FS test. New strategies to reduce time to detection could reduce waiting times for HCV diagnosis, improving linkage to treatment.
AbstractList Abstract Background Xpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit diagnosis and treatment. Methods This study evaluated time to HCV RNA detection using the Xpert HCV VL FS assay. Fingerstick whole-blood samples were collected from participants in an observational cohort in Australia. Results In May 2018–2019, 1468 participants were enrolled, 1426 had Xpert HCV VL FS testing performed, and 1386 had a valid result. HCV RNA was detected in 23% (325/1386). Among people with undetectable HCV RNA (n = 1061), median time to result was 57 minutes. Among people with detectable HCV RNA (n = 325), median time to HCV RNA detection was 32 minutes and 80% (261/325) had a detectable HCV RNA result in ≤40 minutes. Median time to HCV RNA detection was dependent on HCV RNA level. Conclusions A quicker HCV diagnosis could be achieved by monitoring the time when HCV RNA is first detected with the Xpert HCV VL FS test, rather than HCV RNA quantification, although the current platform does not allow for this. These findings could facilitate new strategies to reduce waiting times for an HCV diagnosis and improve linkage to treatment. Among people with detectable HCV RNA, median time to HCV RNA detection was 32 minutes with the Xpert HCV VL FS test. New strategies to reduce time to detection could reduce waiting times for HCV diagnosis, improving linkage to treatment.
Background Xpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit diagnosis and treatment. Methods This study evaluated time to HCV RNA detection using the Xpert HCV VL FS assay. Fingerstick whole-blood samples were collected from participants in an observational cohort in Australia. Results In May 2018–2019, 1468 participants were enrolled, 1426 had Xpert HCV VL FS testing performed, and 1386 had a valid result. HCV RNA was detected in 23% (325/1386). Among people with undetectable HCV RNA (n = 1061), median time to result was 57 minutes. Among people with detectable HCV RNA (n = 325), median time to HCV RNA detection was 32 minutes and 80% (261/325) had a detectable HCV RNA result in ≤40 minutes. Median time to HCV RNA detection was dependent on HCV RNA level. Conclusions A quicker HCV diagnosis could be achieved by monitoring the time when HCV RNA is first detected with the Xpert HCV VL FS test, rather than HCV RNA quantification, although the current platform does not allow for this. These findings could facilitate new strategies to reduce waiting times for an HCV diagnosis and improve linkage to treatment.
Xpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit diagnosis and treatment. This study evaluated time to HCV RNA detection using the Xpert HCV VL FS assay. Fingerstick whole-blood samples were collected from participants in an observational cohort in Australia. In May 2018-2019, 1468 participants were enrolled, 1426 had Xpert HCV VL FS testing performed, and 1386 had a valid result. HCV RNA was detected in 23% (325/1386). Among people with undetectable HCV RNA (n = 1061), median time to result was 57 minutes. Among people with detectable HCV RNA (n = 325), median time to HCV RNA detection was 32 minutes and 80% (261/325) had a detectable HCV RNA result in ≤40 minutes. Median time to HCV RNA detection was dependent on HCV RNA level. A quicker HCV diagnosis could be achieved by monitoring the time when HCV RNA is first detected with the Xpert HCV VL FS test, rather than HCV RNA quantification, although the current platform does not allow for this. These findings could facilitate new strategies to reduce waiting times for an HCV diagnosis and improve linkage to treatment.
BACKGROUNDXpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit diagnosis and treatment. METHODSThis study evaluated time to HCV RNA detection using the Xpert HCV VL FS assay. Fingerstick whole-blood samples were collected from participants in an observational cohort in Australia. RESULTSIn May 2018-2019, 1468 participants were enrolled, 1426 had Xpert HCV VL FS testing performed, and 1386 had a valid result. HCV RNA was detected in 23% (325/1386). Among people with undetectable HCV RNA (n = 1061), median time to result was 57 minutes. Among people with detectable HCV RNA (n = 325), median time to HCV RNA detection was 32 minutes and 80% (261/325) had a detectable HCV RNA result in ≤40 minutes. Median time to HCV RNA detection was dependent on HCV RNA level. CONCLUSIONSA quicker HCV diagnosis could be achieved by monitoring the time when HCV RNA is first detected with the Xpert HCV VL FS test, rather than HCV RNA quantification, although the current platform does not allow for this. These findings could facilitate new strategies to reduce waiting times for an HCV diagnosis and improve linkage to treatment.
Author Silk, David
Catlett, Beth
Martinello, Marianne
Hajarizadeh, Behzad
Cunningham, Philip
Tillakeratne, Shane
Dore, Gregory J
Jayasinghe, Indika
Valerio, Heather
Applegate, Tanya L
Verich, Andrey
Grebely, Jason
Author_xml – sequence: 1
  givenname: Jason
  surname: Grebely
  fullname: Grebely, Jason
  email: jgrebely@kirby.unsw.edu.au
  organization: The Kirby Institute, UNSW, Sydney, Australia
– sequence: 2
  givenname: Beth
  surname: Catlett
  fullname: Catlett, Beth
  organization: The Kirby Institute, UNSW, Sydney, Australia
– sequence: 3
  givenname: Indika
  surname: Jayasinghe
  fullname: Jayasinghe, Indika
  organization: The Kirby Institute, UNSW, Sydney, Australia
– sequence: 4
  givenname: Heather
  surname: Valerio
  fullname: Valerio, Heather
  organization: The Kirby Institute, UNSW, Sydney, Australia
– sequence: 5
  givenname: Behzad
  surname: Hajarizadeh
  fullname: Hajarizadeh, Behzad
  organization: The Kirby Institute, UNSW, Sydney, Australia
– sequence: 6
  givenname: Andrey
  surname: Verich
  fullname: Verich, Andrey
  organization: The Kirby Institute, UNSW, Sydney, Australia
– sequence: 7
  givenname: Philip
  surname: Cunningham
  fullname: Cunningham, Philip
  organization: The Kirby Institute, UNSW, Sydney, Australia
– sequence: 8
  givenname: Marianne
  surname: Martinello
  fullname: Martinello, Marianne
  organization: The Kirby Institute, UNSW, Sydney, Australia
– sequence: 9
  givenname: Shane
  surname: Tillakeratne
  fullname: Tillakeratne, Shane
  organization: The Kirby Institute, UNSW, Sydney, Australia
– sequence: 10
  givenname: David
  surname: Silk
  fullname: Silk, David
  organization: The Kirby Institute, UNSW, Sydney, Australia
– sequence: 11
  givenname: Gregory J
  surname: Dore
  fullname: Dore, Gregory J
  organization: The Kirby Institute, UNSW, Sydney, Australia
– sequence: 12
  givenname: Tanya L
  surname: Applegate
  fullname: Applegate, Tanya L
  organization: The Kirby Institute, UNSW, Sydney, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31993636$$D View this record in MEDLINE/PubMed
BookMark eNqFkbFu2zAQhokiQeO4XTsWB3RpBiWkSFNSt0CJ6wAuWhRp2k2gRNI5VyZVkhryLHnZKrCToUunG_7vPhzuPyVHzjtDyDtGzxmt-AU6qzFebFEpyotXZMYWvMikZPyIzCjN84yVVXVCTmPcUkoFl8VrcsJZVXHJ5Yw83uLOQPJwZZLpEnoH3sLKDCphwgg13GEYI9w4e4h_YrqHdG_g12BCglV994SoHtZeaVii25gQE3a_4ZtHlzJvs1oFA5cxqodPsFQd9pgmvduAgi9-ir6rATW8XIJq43zE-IYcW9VH8_Yw5-TH8vq2XmXrr59v6st11vGqSBnXrbaWFkzmvOVWt1zI1uZM5CIvF5RayUQhbKnbVhULIy2zLWWyswupBaMFn5OPe-8Q_J_RxNTsMHam75UzfoxNzkWZcyopm9AP_6BbPwY3XdfkQpSyrPj04zk531Nd8DEGY5sh4E6Fh4bR5qm2Zl9bc6htWnh_0I7tzugX_LmnCTjbA34c_if7C-rxpQg
CitedBy_id crossref_primary_10_1002_anbr_202100140
crossref_primary_10_1016_j_trim_2022_101721
crossref_primary_10_1002_hsr2_151
crossref_primary_10_1016_j_jhep_2023_04_019
crossref_primary_10_1186_s12954_023_00850_6
crossref_primary_10_1093_infdis_jiaa366
crossref_primary_10_3389_fviro_2021_742722
crossref_primary_10_1093_infdis_jiad453
crossref_primary_10_1016_j_drugpo_2021_103134
crossref_primary_10_1080_14737159_2023_2292645
crossref_primary_10_1016_j_clinre_2020_11_001
crossref_primary_10_1093_ofid_ofaa196
crossref_primary_10_1016_j_clinmicnews_2020_08_003
crossref_primary_10_1038_s41598_020_77813_5
crossref_primary_10_1093_jalm_jfaa150
crossref_primary_10_3390_life13122271
crossref_primary_10_1007_s11606_022_07628_9
Cites_doi 10.1128/JCM.02598-14
10.1016/j.ebiom.2016.08.035
10.1016/S2468-1253(17)30075-4
10.1128/JCM.01091-17
10.1016/j.jhep.2018.03.026
10.1016/j.drugpo.2017.05.022
10.1371/journal.pone.0101554
10.1080/14737159.2017.1400385
10.1128/JCM.02361-15
10.7326/M16-2575
10.15585/mmwr.mm6518a2
10.1111/1753-6405.12560
10.1016/S0140-6736(16)30579-7
10.1016/j.drugpo.2018.08.011
10.1097/QAD.0000000000000068
10.1128/JCM.01691-17
10.1007/s11894-012-0309-x
10.1177/00333549161310S203
10.1093/infdis/jiy114
ContentType Journal Article
Copyright The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020
The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Copyright_xml – notice: The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020
– notice: The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
NAPCQ
7X8
DOI 10.1093/infdis/jiaa037
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList
ProQuest Health & Medical Complete (Alumni)
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1537-6613
EndPage 2049
ExternalDocumentID 10_1093_infdis_jiaa037
31993636
10.1093/infdis/jiaa037
Genre Research Support, Non-U.S. Gov't
Journal Article
Observational Study
GroupedDBID ---
-DZ
-~X
..I
.2P
.I3
.XZ
.ZR
08P
0R~
123
29K
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABZA
AACGO
AACZT
AAHBH
AAHTB
AAJKP
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
AAWTL
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPTD
ABQLI
ABQNK
ABTLG
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACGOD
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
D-I
DAKXR
DIK
DILTD
DU5
D~K
EBS
ECGQY
EE~
EMOBN
ENERS
ESX
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IH2
IOX
J21
JLS
JSG
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
M49
MHKGH
MJL
ML0
N9A
NGC
NOMLY
NOYVH
NU-
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SJN
TCURE
TEORI
TJX
TR2
W2D
W8F
WH7
X7H
YAYTL
YKOAZ
YXANX
~91
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ABEJV
AHMMS
CITATION
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c397t-3dbdff071623b3fdb346bf2142428500f61474f8dbba75e6f1fb016cf56d41073
ISSN 0022-1899
IngestDate Wed Dec 04 08:06:19 EST 2024
Thu Oct 10 17:34:41 EDT 2024
Fri Dec 06 03:31:13 EST 2024
Wed Oct 16 00:44:40 EDT 2024
Wed Sep 11 04:40:02 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords rapid
diagnostics
HCV
testing
PWID
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c397t-3dbdff071623b3fdb346bf2142428500f61474f8dbba75e6f1fb016cf56d41073
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://academic.oup.com/jid/article-pdf/221/12/2043/33724345/jiaa037.pdf
PMID 31993636
PQID 2448689304
PQPubID 41591
PageCount 7
ParticipantIDs proquest_miscellaneous_2348230601
proquest_journals_2448689304
crossref_primary_10_1093_infdis_jiaa037
pubmed_primary_31993636
oup_primary_10_1093_infdis_jiaa037
PublicationCentury 2000
PublicationDate 2020-06-11
PublicationDateYYYYMMDD 2020-06-11
PublicationDate_xml – month: 06
  year: 2020
  text: 2020-06-11
  day: 11
PublicationDecade 2020
PublicationPlace US
PublicationPlace_xml – name: US
– name: United States
– name: Oxford
PublicationTitle The Journal of infectious diseases
PublicationTitleAlternate J Infect Dis
PublicationYear 2020
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Snow (2020090801435031100_CIT0010) 2017; 41
Schwebke (2020090801435031100_CIT0020) 2018; 56
Ling (2020090801435031100_CIT0023) 2018; 56
World Health Organization (2020090801435031100_CIT0004) 2017
Yehia (2020090801435031100_CIT0007) 2014; 9
Buchan (2020090801435031100_CIT0021) 2015; 53
Cepheid, AB (2020090801435031100_CIT0018) 2018
Gonzalez (2020090801435031100_CIT0022) 2016; 54
Janjua (2020090801435031100_CIT0011) 2016; 12
The Kirby Institute (2020090801435031100_CIT0006) 2017
Lamoury (2020090801435031100_CIT0015) 2018; 217
World Health Organization (2020090801435031100_CIT0003) 2017
Pawlotsky (2020090801435031100_CIT0024) 2013; 15
Stanaway (2020090801435031100_CIT0001) 2016; 388
Treatment Action Group (2020090801435031100_CIT0025) 2019
Iversen (2020090801435031100_CIT0012) 2017; 47
Department of Health, Australia (2020090801435031100_CIT0005) 2018
Grebely (2020090801435031100_CIT0013) 2017; 17
Patel (2020090801435031100_CIT0008) 2016; 131
Iversen (2020090801435031100_CIT0026) 2014; 28
European Association for the Study of the Liver (2020090801435031100_CIT0019) 2018; 69
Bajis (2020090801435031100_CIT0016) 2018; 61
Falade-Nwulia (2020090801435031100_CIT0002) 2017; 166
Grebely (2020090801435031100_CIT0014) 2017; 2
World Health Organization (2020090801435031100_CIT0017) 2010
Mera (2020090801435031100_CIT0009) 2016; 65
References_xml – volume-title: Annual surveillance report on HIV, viral hepatitis and STIs in Australia 2017
  year: 2017
  ident: 2020090801435031100_CIT0006
  contributor:
    fullname: The Kirby Institute
– volume: 53
  start-page: 443
  year: 2015
  ident: 2020090801435031100_CIT0021
  article-title: Multicenter clinical evaluation of the Xpert GBS LB assay for detection of group B Streptococcus in prenatal screening specimens
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.02598-14
  contributor:
    fullname: Buchan
– volume: 12
  start-page: 189
  year: 2016
  ident: 2020090801435031100_CIT0011
  article-title: The population level cascade of care for hepatitis C in British Columbia, Canada: the BC hepatitis testers cohort (BC-HTC)
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2016.08.035
  contributor:
    fullname: Janjua
– volume-title: Pipeline report 2019 HCV diagnostics
  year: 2019
  ident: 2020090801435031100_CIT0025
  contributor:
    fullname: Treatment Action Group
– volume: 2
  start-page: 514
  year: 2017
  ident: 2020090801435031100_CIT0014
  article-title: Evaluation of the Xpert HCV viral load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study
  publication-title: Lancet Gastroenterol Hepatol
  doi: 10.1016/S2468-1253(17)30075-4
  contributor:
    fullname: Grebely
– volume: 56
  start-page: e01091-17
  year: 2018
  ident: 2020090801435031100_CIT0020
  article-title: Clinical evaluation of the Cepheid Xpert TV assay for detection of trichomonas vaginalis with prospectively collected specimens from men and women
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01091-17
  contributor:
    fullname: Schwebke
– volume: 69
  start-page: 461
  year: 2018
  ident: 2020090801435031100_CIT0019
  article-title: EASL recommendations on treatment of hepatitis C 2018
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2018.03.026
  contributor:
    fullname: European Association for the Study of the Liver
– volume: 47
  start-page: 77
  year: 2017
  ident: 2020090801435031100_CIT0012
  article-title: Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
  publication-title: Int J Drug Policy
  doi: 10.1016/j.drugpo.2017.05.022
  contributor:
    fullname: Iversen
– volume: 9
  start-page: e101554
  year: 2014
  ident: 2020090801435031100_CIT0007
  article-title: The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0101554
  contributor:
    fullname: Yehia
– year: 2017
  ident: 2020090801435031100_CIT0003
  contributor:
    fullname: World Health Organization
– volume: 17
  start-page: 1109
  year: 2017
  ident: 2020090801435031100_CIT0013
  article-title: Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis
  publication-title: Expert Rev Mol Diagn
  doi: 10.1080/14737159.2017.1400385
  contributor:
    fullname: Grebely
– volume: 54
  start-page: 142
  year: 2016
  ident: 2020090801435031100_CIT0022
  article-title: Multicenter evaluation of the Xpert norovirus assay for detection of norovirus genogroups I and II in fecal specimens
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.02361-15
  contributor:
    fullname: Gonzalez
– volume: 166
  start-page: 637
  year: 2017
  ident: 2020090801435031100_CIT0002
  article-title: Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review
  publication-title: Ann Intern Med
  doi: 10.7326/M16-2575
  contributor:
    fullname: Falade-Nwulia
– volume-title: Fifth national hepatitis C strategy
  year: 2018
  ident: 2020090801435031100_CIT0005
  contributor:
    fullname: Department of Health, Australia
– volume: 65
  start-page: 461
  year: 2016
  ident: 2020090801435031100_CIT0009
  article-title: Identification and clinical management of persons with chronic hepatitis C virus infection - Cherokee Nation, 2012-2015
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6518a2
  contributor:
    fullname: Mera
– volume: 41
  start-page: 193
  year: 2017
  ident: 2020090801435031100_CIT0010
  article-title: Limited provision of diagnostic services to Victorians living with hepatitis C antibodies, 2001-2012: a multi-level modelling analysis
  publication-title: Aust N Z J Public Health
  doi: 10.1111/1753-6405.12560
  contributor:
    fullname: Snow
– volume-title: Global hepatitis report 2017
  year: 2017
  ident: 2020090801435031100_CIT0004
  contributor:
    fullname: World Health Organization
– volume: 388
  start-page: 1081
  year: 2016
  ident: 2020090801435031100_CIT0001
  article-title: The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)30579-7
  contributor:
    fullname: Stanaway
– volume: 61
  start-page: 23
  year: 2018
  ident: 2020090801435031100_CIT0016
  article-title: Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia
  publication-title: Int J Drug Policy
  doi: 10.1016/j.drugpo.2018.08.011
  contributor:
    fullname: Bajis
– volume: 28
  start-page: 275
  year: 2014
  ident: 2020090801435031100_CIT0026
  article-title: Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000000068
  contributor:
    fullname: Iversen
– volume: 56
  start-page: e01691-17
  year: 2018
  ident: 2020090801435031100_CIT0023
  article-title: Parallel validation of three molecular devices for simultaneous detection and identification of influenza A and B and respiratory syncytial viruses
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01691-17
  contributor:
    fullname: Ling
– volume: 15
  start-page: 309
  year: 2013
  ident: 2020090801435031100_CIT0024
  article-title: Treatment of hepatitis C: how will we use viral kinetics, response-guided therapy?
  publication-title: Curr Gastroenterol Rep
  doi: 10.1007/s11894-012-0309-x
  contributor:
    fullname: Pawlotsky
– volume: 131
  start-page: 12
  year: 2016
  ident: 2020090801435031100_CIT0008
  article-title: Results of hepatitis C birth-cohort testing and linkage to care in selected U.S. sites, 2012–2014
  publication-title: Public Health Rep
  doi: 10.1177/00333549161310S203
  contributor:
    fullname: Patel
– volume-title: Xpert® HCV VL Fingerstick. Sweden
  year: 2018
  ident: 2020090801435031100_CIT0018
  contributor:
    fullname: Cepheid, AB
– volume: 217
  start-page: 1889
  year: 2018
  ident: 2020090801435031100_CIT0015
  article-title: Evaluation of the Xpert HCV viral load finger-stick point-of-care assay
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiy114
  contributor:
    fullname: Lamoury
– volume-title: WHO guidelines on drawing blood: best practices in phlebotomy
  year: 2010
  ident: 2020090801435031100_CIT0017
  contributor:
    fullname: World Health Organization
SSID ssj0004367
Score 2.4621582
Snippet Abstract Background Xpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit...
Xpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit diagnosis and treatment....
Background Xpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit diagnosis and...
BACKGROUNDXpert HCV Viral Load Fingerstick assay (Xpert HCV VL FS) is a point-of-care test quantifying HCV RNA in <1 hour, enabling same-visit diagnosis and...
SourceID proquest
crossref
pubmed
oup
SourceType Aggregation Database
Index Database
Publisher
StartPage 2043
SubjectTerms Adult
Blood Specimen Collection - instrumentation
Blood tests
Diagnosis
Feasibility Studies
Female
Fingers
Hepacivirus - genetics
Hepacivirus - isolation & purification
Hepatitis
Hepatitis C
Hepatitis C - blood
Hepatitis C - diagnosis
Hepatitis C - virology
Humans
Interferon
Male
Medical diagnosis
Middle Aged
Point of care testing
Reagent Kits, Diagnostic
Ribonucleic acid
RNA
RNA, Viral - blood
RNA, Viral - isolation & purification
Time Factors
Viral Load
Title Time to Detection of Hepatitis C Virus Infection With the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis
URI https://www.ncbi.nlm.nih.gov/pubmed/31993636
https://www.proquest.com/docview/2448689304
https://search.proquest.com/docview/2348230601
Volume 221
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKEIgXBOOrMJBBSDxEYWntuhlv0K2UsQ2E2q1vkZ3YIkw0VZs-jL_CP-BXcq_tpKmYxOAlau3UtXJOrq_te48JecnNHu9w1Q2FUHHITScNY8lEyHkf9d8UTIowd_j4RIwm_HDam7ZavxpRS6tSvU5_XJpX8j-oQhngilmy_4Bs3SgUwGfAF66AMFyvhnH-3Z58sa9LnVau30hjkHSZL4NBcJovVkuwAcZXn9lVV2DGdK4XZTAanOItuJZdyCwY2iU-FG4-Dz4X-awMCxNighKCKK001FCmXtYbcxvBIkDlFznPs6Dui4vdy5dNt3edgOY1KlyHoG9-g6j27N8vAG93-vWhXK5jBAYS2nEbWe9cEJoL_JEXElc7vmpn7LL8vB5nTmHsW-SFG1yto9tc4ujiSTihN8G6Mst9YJPLWq3sdtelVlcE7TbNcOS0n_yQDl_3Lh0unJQWFGUo6DD8lksZOQ2aTWXuk0_JcHJ0lIwPpuNr5DqKLuI5DfsfPq5zcJno16KgbNe1uetb3HB6NhIp_5jPWL9mfIfc9qjQt45dd0lLz7bJDXdE6cU2uXnsgy_ukZ8IMS0LWtONFobWdKMDaulGa7pRpBuFB08t3SjQjVq6UaQbbdCNbtCNWrq9oU2yUUmRbNSSjdY9qch2n0yGB-PBKPRne4QpeMBlyDKVGROhfhlTzGSKcaEM6v_BfLgXRQbcxj43caaU7Pe0MB2jYHaSmp7IeAfGpQdka1bM9CNCFVNaouxRHGfcZFJlkQQ_lQtupAYHuE1eVQ8_mTsJl8SFXrDEwZR4mNrkBWDz15t2KugSbwuWCTjJsQDXP-Jt8ryuBkuN229ypuGFSrqoI8VQ_6hNHjrI679iGEcrmHh8hV8_IbfWL8kO2SoXK_0UPONSPbOU_A2OdsAl
link.rule.ids 314,780,784,27924,27925
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Time+to+Detection+of+Hepatitis+C+Virus+Infection+With+the+Xpert+HCV+Viral+Load+Fingerstick+Point-of-Care+Assay%3A+Facilitating+a+More+Rapid+Time+to+Diagnosis&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Grebely%2C+Jason&rft.au=Catlett%2C+Beth&rft.au=Jayasinghe%2C+Indika&rft.au=Valerio%2C+Heather&rft.date=2020-06-11&rft.eissn=1537-6613&rft.volume=221&rft.issue=12&rft.spage=2043&rft.epage=2049&rft_id=info:doi/10.1093%2Finfdis%2Fjiaa037&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon